Search research articles
Contact Us
Filters
Showing results (581-590 of 815) with videos related to
Page
of 82
Sort By:
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Chemical Neuroscience
|
July 9, 2014
Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis
Paul C Trippier, Kevin Tianmeng Zhao, Susan G Fox, et al.
Frontiers in Pediatrics
|
January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocols
Giacomo Gotti, Yael Flamand, Victoria Koch, et al.
Gastrointestinal Endoscopy
|
October 25, 2002
Wireless capsule endoscopy: August 2002
Gregory G Ginsberg, Alan N Barkun, John J Bosco, et al.
Pediatric Blood & Cancer
|
December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia
Yaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Pediatric Blood & Cancer
|
July 2, 2011
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis
Deborah P Waber, Jennifer Turek Queally, Lori Catania, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1996
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood
M M Lee, P K Donahoe, T Hasegawa, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Journal of Neurointerventional Surgery
|
October 3, 2022
Asymptomatic carotid artery stenosis: a summary of current state of evidence for revascularization and emerging high-risk features
Hyun Woo Kim, Robert W Regenhardt, Salvatore A D'Amato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2003
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
John M Goldberg, Lewis B Silverman, Donna E Levy, et al.
Page
of 82
Search research articles
Search
Showing results (581-590 of 815) with videos related to
Sort By:
Page
of 82
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Chemical Neuroscience
|
July 9, 2014
Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis
Paul C Trippier, Kevin Tianmeng Zhao, Susan G Fox, et al.
Frontiers in Pediatrics
|
January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocols
Giacomo Gotti, Yael Flamand, Victoria Koch, et al.
Gastrointestinal Endoscopy
|
October 25, 2002
Wireless capsule endoscopy: August 2002
Gregory G Ginsberg, Alan N Barkun, John J Bosco, et al.
Pediatric Blood & Cancer
|
December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia
Yaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Pediatric Blood & Cancer
|
July 2, 2011
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis
Deborah P Waber, Jennifer Turek Queally, Lori Catania, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1996
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood
M M Lee, P K Donahoe, T Hasegawa, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Journal of Neurointerventional Surgery
|
October 3, 2022
Asymptomatic carotid artery stenosis: a summary of current state of evidence for revascularization and emerging high-risk features
Hyun Woo Kim, Robert W Regenhardt, Salvatore A D'Amato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2003
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
John M Goldberg, Lewis B Silverman, Donna E Levy, et al.
Page
of 82